InVivo Therapeutics Holdings CorpCompany Review & Valuation

NVIV
Nasdaq
Latest Price
1.43USD
Market Capitalization
2,212.67kUSD

About InVivo Therapeutics Holdings Corp

InVivo Therapeutics Holdings Corp., a research and clinical-stage biomaterials and biotechnology company, engages in developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries. It is developing Neuro-Spinal Scaffold implant, an investigational bioresorbabShow morele polymer scaffold for implantation at the site of injury within a spinal cord. InVivo Therapeutics Holdings Corp. has research collaboration with the Q Therapeutics, Inc. for the evaluation of the combination of PLGA-PLL based Neuro-Spinal Scaffold with adult neural progenitor cells, including those from induced pluripotent stem cells. The company was founded in 2005 and is headquartered in Cambridge, Massachusetts.Show less

Industry
Biotechnology
HQ Location
Cambridge, Massachusetts

Stock Price

Price data not available for InVivo Therapeutics Holdings Corp.

Performance

Please login or create a free account to view the contents of this section.

Similar Companies

Alexion Pharmaceuticals
Valneva
Ovoca Bio
BioCryst Pharmaceuticals

back to top